Single answer
Is AstraZeneca PLC (AZN) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.10 or 10.32%
(In 50 weeks 1 day 8 hours 24 minutes and 23 seconds .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for AstraZeneca PLC is $102.67, which is $10.74 (11.68%) above the current price today's price.
Low target: $97.00 | High target: $108.00
Company snapshot
A quick overview of the business and its public profile.
AstraZeneca PLC a biopharmaceutical company focuses on the discovery development manufacture and commercialization of prescription medicines The companys marketed products include Tagrisso Imfinzi Lynparza Calquence Enhertu Orpathys Truqap Zoladex Faslodex Farxiga Brilinta Lokelma Roxadustat Andexxa Crestor Seloken Onglyza Bydureon Fasenra Breztri Symbicort Saphnelo Tezspire Pulmicort Bevespi and Daliresp for cardiovascular renal metabolism and oncology Its marketed products also comprise Vaxzevria Beyfortus Synagis FluMist Soliris Ultomiris Strensiq Koselugo and Kanuma for covid19 and rare disease The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom rest of Europe the Americas Asia Africa and Australasia It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006 BenevolentAI for drug discovery for systemic lupus erythematosus Lunit for developing AIPowered Digital Pathology Risk Assessment Tools for NSCLC and Absci Corporation for AIdriven drug discovery against an oncology target The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999 AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge the United Kingdom
Website: https://www.astrazeneca.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.14 and is down -0.0800 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.29. Cash flow to debt ratio: 0.46. Net profit margin: 16.17%. Inflation risk score: low (0.40/1).
Dividend history check
Yes, AstraZeneca PLC pays dividends. Last payment was 2025-09-08 for holders on 2025-08-08. Over 66 payments between 1993 and 2025, total $53.28 with an average of $0.807 per share. Last dividend was $0.515.
Trading liquidity
Yes, the average daily trading liquidity for AstraZeneca PLC is $407.3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On AstraZeneca PLC, 2015-12-31 had a stock price of $33.95. If you invested back then, your return now would be a profit of $57.98 per share or 170.78%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.